CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 11 - 20 of 1130
Study Number Lead Group Study Title CIRB Study Status
A092105 Alliance Randomized Phase 2 Study of Nivolumab and Ipilimumab with or without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma that have Progressed after Platinum Treatment and Immunotherapy Adult CIRB - Late Phase Emphasis Available to Open
A091802 Alliance Phase II Randomized Trial of Avelumab Plus Cetuximab versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC) Adult CIRB - Late Phase Emphasis Available to Open
A022104 Alliance The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing the Efficacy of Triplet versus Doublet Chemotherapy to Achieve Clinical Response in Patients with Locally Advanced Rectal Cancer Adult CIRB - Late Phase Emphasis Available to Open
A051701 Alliance Randomized Phase II/III Study of Venetoclax (ABT 199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double-Expressing Lymphomas Adult CIRB - Late Phase Emphasis Available to Open
A071601 Alliance Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas Adult CIRB - Late Phase Emphasis Available to Open
A191402CD Alliance Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men Cancer Prevention and Control CIRB Completed
A041501 Alliance A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL Adult CIRB - Late Phase Emphasis Available to Open
A061402 Alliance Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy Adult CIRB - Late Phase Emphasis Available to Open
A022106 Alliance Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM) Adult CIRB - Late Phase Emphasis Available to Open
A031801 Alliance A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (RADICAL) Adult CIRB - Late Phase Emphasis Available to Open
Displaying 11 - 20 of 1130